CorMedix (CRMD) Assets Average (2011 - 2025)

CorMedix has disclosed Assets Average across 13 years of filings, most recently posting $788.5 million for Q4 2025.

• Assets Average for Q4 2025 came in at $788.5 million, up 702.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $788.5 million (up 702.82% YoY), and the FY2025 annual result was $472.5 million, up 370.36% from the prior year.
• Assets Average came in at $788.5 million for Q4 2025 at CorMedix, up from $501.7 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $788.5 million in Q4 2025 to a low of $58.1 million in Q2 2023.
• The 5-year median for Assets Average is $73.2 million (2021), against an average of $138.4 million.
• Across the five-year window, Assets Average retreated 19.64% in 2022 and soared 702.82% in 2025, its largest moves.
• CorMedix's Assets Average stood at $72.2 million in 2021, then decreased by 14.01% to $62.1 million in 2022, then surged by 39.78% to $86.7 million in 2023, then grew by 13.22% to $98.2 million in 2024, then jumped by 702.82% to $788.5 million in 2025.
• The last three Assets Average figures came in at $788.5 million (Q4 2025), $501.7 million (Q3 2025), and $201.1 million (Q2 2025), per Business Quant data.